Last Updated: May 16, 2018.
By Dennis Thompson
WEDNESDAY, May 16, 2018 (HealthDay News) — Less appears to be more when it comes to treating epilepsy with the marijuana extract cannabidiol, a new clinical trial suggests.
Patients taking a 10-milligram (mg) daily dose of pharmaceutical grade cannabidiol (CBD) experienced nearly as great a reduction in seizures as patients on 20 mg, and
... read more at: https://www.doctorslounge.com/index.php/news/hd/80534